- Home
- BBIO vs ONON Comparison
BBIO vs ONON Comparison
Compare BBIO & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | ONON |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 15.3B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BBIO | ONON |
|---|---|---|
| Price | $70.20 | $39.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 21 |
| Target Price | ★ $83.00 | $60.38 |
| AVG Volume (30 Days) | 2.4M | ★ 5.3M |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $88.86 | $24.42 |
| Revenue Next Year | $74.11 | $20.77 |
| P/E Ratio | ★ N/A | $56.05 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $28.33 | $34.38 |
| 52 Week High | $84.94 | $61.29 |
Technical Indicators
Market Signals| Indicator | BBIO | ONON |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 34.15 |
| Support Level | $61.95 | $34.38 |
| Resistance Level | $78.20 | $44.10 |
| Average True Range (ATR) | 2.75 | 1.75 |
| MACD | 0.64 | -0.46 |
| Stochastic Oscillator | 56.57 | 14.54 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.